Correspondence 0001104659-23-125717 from FENNEC PHARMACEUTICALS INC. (FENC) (CIK 0001211583) (FENC)
FENNEC PHARMACEUTICALS INC. (FENC) (CIK 0001211583)
Date: Dec. 13, 2023 · CIK: 0001211583 · Accession: 0001104659-23-125717
AI Filing Summary & Sentiment
File numbers found in text: 333-275452
Letter
Fennec Pharmaceuticals Inc.
PO Box 13628, 68 TW Alexander Drive
Research Triangle Park, NC 27709
December 13, 2023
Via EDGAR Correspondence
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F. Street, N.E.
Washington D. C. 20549
Re: Acceleration of Effective Date
Fennec Pharmaceuticals Inc.
Registration Statement on Form S-3
File No. 333-275452
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:30 p.m., Eastern Time, on December 15, 2023, or as soon thereafter as is practicable.
Very truly yours,
FENNEC PHARMACEUTICALS INC.
Show Raw Text
CORRESP
1
filename1.htm
Fennec Pharmaceuticals Inc.
PO Box 13628, 68 TW Alexander Drive
Research Triangle Park, NC 27709
December 13, 2023
Via EDGAR Correspondence
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F. Street, N.E.
Washington D. C. 20549
Re: Acceleration
of Effective Date
Fennec Pharmaceuticals Inc.
Registration Statement on Form S-3
File No. 333-275452
Ladies and Gentlemen:
In accordance with Rule 461
under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date of the above-referenced Registration
Statement be accelerated so that the same will become effective at 4:30 p.m., Eastern Time, on December 15, 2023, or as soon thereafter
as is practicable.
Very truly yours,
FENNEC PHARMACEUTICALS INC.
By: /s/ Rostislav Raykov
Rostislav Raykov
Chief Executive Officer